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Human infants born prematurely between 23-32 weeks have a predisposition toward 
sustaining white matter injury (WMI).  In survivors of preterm birth, hypoxic-ischemic (H-
I) damage to the cerebral white matter is the leading cause of a spectrum of neurological 
and motor deficits and in severe cases, cerebral palsy (CP).  H-I triggers extracellular 
matrix (ECM) breakdown leading to production of inhibitory ECM components. H-I also 
induces vigorous proliferation of oligodendrocyte progenitor cells (OPCs) leading to 
accumulation of the pre-oligodendrocytes (preOLs).  However, these preOLs fail to 
differentiate and generate myelin producing oligodendrocytes (OLs). Mechanistically, 
ECM breakdown blocks repair and regeneration of myelin following WMI as hyaluronic 
acid (HA), a major component of the brain ECM, is digested into bioactive fragments 
(fHA).  Previous studies have shown that following WMI, HA degraded by PH20 
hyaluronidase to fHA prevents differentiation of preOLs to mature OLs, but whether fHA 
plays a role in H-I mediated OPC proliferation is unknown.  To determine if hyaluronidase 
plays a role in vivo to promote OPC proliferation, we utilized a neonatal rodent preterm 
model of H-I and a new selective PH20 inhibitor, SuBr3.  Our hypothesis tests whether 
SuBr3 mediated inhibition of PH20 activity will also attenuate the OPC proliferation 
response observed after neonatal WMI. We found a significant decrease in Ki67+ cells in 
WMI lesions in the SuBr3 treated animals relative to all other control groups, suggesting 
total cell proliferation was attenuated and mediated by PH20 hyaluronidase activity. Future 
experiments will analyze whether SuBr3 treatment also results in changes in the total pool 




Each year, an estimated 15 million babies are born premature (Blencowe et al., 2013).  In 
the United States, ten percent of all live births per year are preterm (CDC, 2014). Despite 
new therapies, prematurity is the leading cause of abnormal brain maturation that is 
associated with impaired neurodevelopment in preterm neonates, including motor, 
cognitive, behavioral, or sensory deficits (Chau et al., 2013; Back and Miller, 2014; Back 
and Rosenberg, 2014). During human brain development, infants born between 23-32 
weeks of gestation age have a predisposition toward white matter injury (WMI) (Back et 
al., 2001; Volpe, 2009). Preterm infants have a narrow auto-regulation window where 
cerebral blood flow (CBF) to the brain decreases when arterial blood pressure drops 
(Khwaja and Volpe, 2008).  Inefficient or reduced oxygen and blood to the brain and lungs 
cause injury and is termed Hypoxia-Ischemia (H-I). Hence, WMI is triggered by an 
interaction of factors relating to cerebrovascular immaturity and impaired cerebral blood 
flow that cause complications during pre-term birth. 
One of the hallmarks of WMI is myelination failure (Back and Rosenberg, 2014). 
Myelin is the insulation around the nerve fibers that allows quick transfer of information 
within the brain aiding in cognitive, motor and sensory functions. During human brain 
development, when neonates are most vulnerable to WMI (~23-32 gestation age), pre-
myelinating oligodendrocytes (pre-OLs) are the dominant population in the brain (Back et 
al., 2001). Pre-OLs are the precursor glial cell to mature oligodendrocytes (OLs), a 
specialized glial cell that produces myelin. Pre-OLs are sensitive to H-I insults associated 
with WMI and pre-term birth (Back et al., 2001; Back et al., 2002; Craig et al., 2003; Back 
and Rosenberg, 2014). Thus, pre-term birth disrupts the inception of myelination as pre-
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existing pre-OLs die and the newly born pre-OLs fail to mature to the next successive stage. 
Previous studies have defined the sequential maturation of the OL lineage into four distinct 
stages: oligodendrocyte progenitor cell (OPC), pre-OL, immature OL, and mature 
(myelinating) OL (Back et al., 2002) (Fig. 1).  
The regeneration and repair story for myelin indicates that it is much more complex 
than research originally predicted. Previous studies have defined a novel mechanism of 
myelination failure that disrupts the sequential maturation of the OL lineage in WMI (Back 
et al., 2002). During the early phase of white matter brain injury, preOL death occurs. This 
phase is followed by a vigorous regenerative response of oligodendrocyte progenitor cells 
(OPCs) that re-expand the pre-oligodendrocyte (preOL) pool. However, these newly 
generated preOLs cease to differentiate, and the OL lineage fails to mature to the next 
successive stage (Segovia et al., 2008). Myelin is no longer generated. This abnormal 
proliferation and maturation of OLs contributes to aberrant brain repair after injury and has 
been linked to extracellular matrix (ECM) breakdown (Sherman et al., 2015). 
ECM breakdown is considered one of the main events that influences myelination 
failure following WMI, but the molecular mechanisms are poorly defined (Lau et al., 
2013).  The brain ECM regulates the central nervous system (CNS) in diverse ways and 
significant changes in its physiology have consequences to its function. WMI compromises 
the integrity of the blood-brain barrier (BBB) and the endothelial cells lining the blood 
vessels break down leading to monocyte infiltration and reactive gliosis (Shechter et al., 
2013). A glial scar forms in response to reactive astrogliosis from the demyelinating white 
matter.  Reactive astrogliosis is characterized by proliferating astrocytes as a maladaptive 
response to altered ECM homeostasis. Furthermore, this newly formed glial scar produces 
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an abnormal ECM as it contains altered levels of hyaluronic acid (HA) (Back et al., 2005). 
Hence, WMI induced ECM remodeling generates an altered micro-environment that 
ultimately attenuates remyelination and repair. 
Hyaluronic acid (HA) is a prominent component of the brain ECM that provides 
structural and functional support thereby regulating cellular homeostasis (Rauch, 2004). 
HA is a glycosaminoglycan composed of disaccharide units of glucuronic acid and N-
acetyl-D-glucosamine synthesized by transmembrane synthases (Sherman and Back, 
2008).  WMI results in the formation of the glial scar containing altered levels of HA, 
indicating that HA can play a significant role in influencing myelin repair. Furthermore, 
experiments have shown that remyelination failure is due to accumulation of a specific 
high molecular weight (HMW) form of HA synthesized by reactive proliferating astrocytes 
(astrogliosis) and other microglial cells within the lesions (Back et al., 2005). 
HMW forms of HA found in the white matter lesions have been proposed to be 
digested into bioactive forms by a selective hyaluronidase enzyme, PH20, found in the 
CNS (Preston et al., 2013). This generation of digested bioactive HA fragments (fHA) by 
PH20 hyaluronidase is responsible for arresting preOL maturation following injury in an 
adult rodent model of demyelination. Correspondingly, an elevated expression of PH20 
hyaluronidase was found in the demyelinated brain lesions. Understanding the molecular 
mechanisms mediated by PH20 will aid in development of possible therapies to promote 
regeneration and repair following neonatal WMI. Degradation of HMW-HA by 
hyaluronidases stimulates cell proliferation (Su et al., 2017) and similarly, WMI induces 
proliferation of glial cells as well as OPCs (Segovia et al., 2008); it is not clear whether 
WMI induced HMW-HA breakdown can also influence OPC proliferation.  
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Using a neonatal rodent pre-term equivalent model of Hypoxia-Ischemia, we tested 
whether blocking HMW-HA degradation can influence myelination and repair following 
WMI. This rodent model successfully emulates all the defining features of WMI observed 
in human patients namely, ECM breakdown, OPC proliferation and OL maturation arrest. 
Similar to human preterm WMI, the lesions generated by our well-established neonatal 
rodent H-I model are also highly enriched in GFAP+ reactive astrocytes and display marked 
elevations in staining for HA that coincide with extensive myelination failure. Previous 
studies have been able to promote oligodendrocyte maturation using general hyaluronidase 
inhibitors in vitro (Preston et al., 2013). We investigated the molecular mechanisms 
influencing OPC proliferation following WMI by employing an in vivo approach using a 
new selective hyaluronidase inhibitor, SuBr3, that prevents HMW-HA breakdown. Our 
preliminary studies reveal that SuBr3 treatment attenuates the proliferation of cells in H-I 
induced white matter lesions thereby implicating influence of HMW-HA breakdown on 
cell cycle. Hence, the use of this new selective hyaluronidase inhibitor, SuBr3, will allow 
us to provide further insights into strategies to promote preOL maturation that ultimately 
improve the neurological outcome for children with neurodevelopmental disabilities 



























Figure 1. The four sequential stages of the oligodendrocyte (OL) lineage after 
white matter injury (WMI). The red line indicates failure of pre-oligodendrocytes 
(preOLs) to differentiate and generate myelin after a vigorous proliferation of 




Materials and Methods: 
Animal Surgical Procedures   
All animal measures were approved by the OHSU Institutional Animal Care and Use 
Committee (IACUC) according to the NIH Guide for the Care and Use of Laboratory 
Animals. Timed pregnant Sprague-Dawley (SD) rats were purchased from Charles River 
(Hollister, CA, USA). At postnatal day 3 (P3), animals were anaesthetized and received a 
single injection of 2M SuBr3 (final concentration) or equivalent volume of vehicle 
(DMSO) into the left hemisphere. This was immediately followed a hypoxic-ischemic 
protocol with the left common carotid artery ligation (10 pups/litter) to generate focal 
cerebral injury lateralized to one hemisphere with the contralateral hemisphere serving as 
a control (Vannucci, 1999; Segovia et. al, 2008). Following a minimum of 1h recovery 
with their dams, pups were placed into containers (submerged into a 37oC water bath to 
maintain normothermia) aerated with humidified oxygen (6% for 3.5h) and balanced 
nitrogen at 3 L/min. The pups were then returned to their dams until sacrifice (Hypoxia-
Ischemia [H-I] group). Animals survived for 4 days (until P7). A set of animals were also 
recovered without receiving surgery/ischemia and were treated as un-injured controls.  
Animals were sacrificed by decapitation following anesthesia. The brains were 
quickly dissected out and assessed for the presence of lesions. Only brains exhibiting well-
defined brain lesions were included in this study. A set of lesioned brains were collected 
and fixed in 4% paraformaldehyde (PFA; 0.1 M phosphate buffered saline [PBS]) for 2 
days at 4oC, followed by thorough PBS washing for immunohistochemistry (IHC). For 
each experimental outcome, a minimum of three brain sections were used for each group 




Single- or double-labeling immunofluorescence was performed on 50M thick brain 
sections cut with a Vibratome (Leica VT1000) in 24-well plates. Antibodies and dilutions 
were as follows: mouse polyclonal anti-GFAP (1:500; EMD Millipore), rabbit polyclonal 
anti-Ki67 (1:100; Leica, USA), and mouse monoclonal anti-olig2 (1:250; Dr. John Alberta, 
Dana-Farber Cancer Institute, Boston, MA, USA). For all the antibodies used the sections 
underwent the antigen retrieval procedure wherein the sections were incubated in 0.01 M 
citrate buffer (pH 6.0) at 85°C for 15 min, left to cool for 10 min, and then washed three 
times in PBS. For labeling, sections were blocked for 1h in PBS containing 5% normal 
goat serum (NGS), and then with primary antibodies diluted in PBS/3% NGS for 3-4 nights 
at 4°C. Blocking and primary antibody incubation was performed with 0.4% triton X-100 
(Sigma-Aldrich Co.). For secondary detection, all sections were washed three times in 
PBS, and incubated with appropriate fluorescent dye conjugated secondary antibodies 
(Jackson Research Labs). Nuclei were counterstained with DAPI (Invitrogen Co.). 
Sections were mounted with Vectashield fluorescent mounting medium (Vector 
Laboratories, Inc., Burlingame, CA, USA).  
 
Quantification of Total Cell Count of GFAP+ and Ki67+-labeled Cells 
The white matter of sectioned tissue slices was analyzed using a Ziess Imager.M2 
microscope (Carl Ziess Microscopy, Thornwood, NY, USA) coupled to a Stereo-
Investigator (SI) stereology system (MBF Bioscience, Williston, VT, USA). For each 
histological (serial) section slice, the superior corpus callosum (defined by DAPI-staining) 
region of interest (ROI) was traced at 5x magnification. Using the software to maintain 
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white matter boundaries,  GFAP+ and Ki67+-labeled cells were estimated in the superior 
corpus callosum using the Optical Fractionator probe (Counting frame, 40×40μm; z-depth, 
20μm) at 100X oil magnification. Cells were counted in a minimum of three adjacent 
coronal sections (300μm apart) in lesions and their corresponding control regions in the 
contralateral hemisphere. A minimum of 20 randomly selected white matter fields was 
counted per slice. The slice thickness was also measured at each counting site. The total 
number of counted nucleus profiles comprised the calculation of the total cell count.  
 
Quantification of Total Cell Count of Olig2+, Ki67+, Olig2+-Ki67+-labeled Cells 
From the same perinatal rodents, tissue sections were immunofluorescently double-labeled 
for Olig2 and Ki67. Quantification of total Olig2+, Ki67+ and Olig2+-Ki67+-labeled cells 
was determined in tissue sections with the same regional boundaries as GFAP+ or Ki67+-
labeled cells. Lesion hemispheres were identified via histology by typical reactive 
appearance of early OL progenitors plus preOL and OL death. The white matter of 
sectioned tissue slices was analyzed using the same Ziess Imager.M2 microscope coupled 
to a SI stereology system. Cell profiles were counted with a 100X objective. For each slice, 
the superior corpus callosum was traced at 5x magnification. Using SI stereology system 
to maintain white matter boundaries,  three separate markers were used to make cells counts 
for Olig2+, Ki67+ and double-labeled Olig2+-Ki67+ cells. Cells were estimated in the 
superior corpus callosum using the Optical Fractionator probe (Counting frame, 40×40μm; 
z-depth, 20μm) at 100X oil magnification. Because of the complexity of injury in animals, 
each coronal section was categorized A, B, or C signifying the location of sections in the 
brain as rostral, medial, or caudal respectively. A minimum of 20 randomly selected white 
matter fields was counted per slice and slice thickness was measured at each counting site. 
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The total number of counted nucleus profiles of OL lineage cells comprised the calculation 
of the total cell count.  
 
Image and Statistical Analysis 
Microscope images were analyzed using Fiji ImageJ software. Data from slice counts were 
analyzed using multiple comparisons with ordinary one-way ANOVA with Prism Version 
7.0 (GraphPad Software, Inc., La Jolla, CA, USA). All data were normally distributed and 
expressed as standard error of mean (+/- SEM). To determine the effect of H-I on total cell 
measurements, we used mean cerebral thickness as a marker for spatial distribution of total 
cell count. For each lesion and corresponding contralateral control region, cerebral 
thickness was measured between first and last nucleus in focus within counting grid of the 
SI stereology probe. Three thickness measurements were obtained at the medial, midpoint, 
and lateral boundaries of the lesion within the superior corpus callosum contoured region 
of interest (ROI). First, data analysis was performed on each individual animal case within 
H-I groups (DMSO H-I and SuBr3 H-I) between H-I lesion and the contralateral control 
hemisphere. Because biological variability exists between animals, we accounted for the 
degree of injury between each individual animal when comparing total cells counts 
between treatment groups. Multiple comparisons with ordinary one-way ANOVA was run 
between pooled control and H-I groups to determine relative cell loss due to induced H-I. 
Means with error bars are presented in all figures with significance indicated for statistical 
analyses. A p-value less than 0.05 was considered statistically significant. (For all figures, 
*p  0.05, **p  0.01, ***p    0.001 refer to analysis of data significance for cerebral cell 













Figure 2.  Hypoxic-ischemic (H-I) brain tissue cut on coronal plane with a 
Vibratome (Leica VT1000).  Representative image of the area of counting in the 
superior corpus callosum (CC) of SuBr3-injected (2μM) animals. The blue and 
red box indicates area of counting in the control and lesion hemisphere, 





Using Reactive Astrogliosis to define WMI induced lesions following Hypoxia-Ischemia 
Previous studies using post-mortem tissue derived from preterm human infants suggest that 
arrested maturation of preOLs is associated with ECM remodeling leading to HA 
accumulation and reactive gliosis (Buser et al., 2012). Our preterm equivalent rodent model 
also undergoes preOL arrest following H-I (Segovia et al., 2008) but whether this is 
accompanied with ECM remodeling leading to changes in HA levels in the neonatal lesions 
remains unknown. To study mechanisms of ECM remodeling in the lesions we first defined 
the H-I induced lesions. We used GFAP as a marker for defining the H-I induced lesion as 
elevated astrocyte expression in response to H-I corresponds to injury in vivo (Lyck et al., 
2008). We determined the severity of injury in animals given either SuBr3 (to block ECM 
remodeling) or Vehicle (DMSO) and then subjected to H-I. In the SuBr3 group, the 
population of GFAP+-labeled astrocytes increased in lesioned areas compared to 
corresponding contralateral control region (Fig. 3). And the same was the case with DMSO 
H-I group (B1-B3) (Fig. 4). Increase in GFAP+ astrocytes in both the groups (DMSO and 
SuBr3) following H-I indicates that the lesions were induced following injury. 
We also observed biological variability within the SuBr3 and DMSO H-I 
experimental groups. Cell counts from Animal A2* do not reflect injury after H-I (Fig. 3). 
In fact, we observed a downward trend in the total cell count of the lesioned hemisphere 
compared to the contralateral control hemisphere, which could be increased cell death or 
cell migration following H-I. After review, we found the lesion as defined by GFAP+ 
astrocytes fell outside the region of counting defined within the superior corpus callosum 
(Fig. 2). Because we used a conservative systematic sampling approach via stereology, 
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lesions outside the counting region will not reflect injury, however, we did confirm injury 
through histology. Similarly, in the DMSO H-I group animal B3, the contralateral un-
lesioned hemisphere had variable expression of GFAP+ astrocytes (Fig.4). Hence, these 
results helped us narrow down the cohort of animals that had sustained WMI following H-
I that we then utilized for our subsequent analysis for ECM remodeling and its effects on 
preOL maturation.  
 
SuBr3 Attenuates Total Cell Proliferation after Hypoxia-Ischemia  
ECM remodeling induced breakdown of HA by hyaluronidases leads to cell proliferation 
(Su et al., 2017). In our preterm equivalent rodent model, H-I apart from inducing preOL 
arrest also induces OPC proliferation (Segovia et al., 2008). It remains unknown whether 
ECM remodeling is linked to regulating OPC proliferation in our rodent model following 
H-I. Using a new class of selective hyaluronidase inhibitor, SuBr3, we investigated if HA 
breakdown regulates cell proliferation. After confirming the lesions in the different 
experimental and control groups with GFAP, proliferating cells within these lesions were 
identified with the cycle-cell proliferation marker Ki67 (Scholzen and Gerdes, 2000). The 
lesions in the DMSO H-I group displayed a non-significant increase in the total number 
of Ki67+ cells (Fig.6) suggesting that injury promotes cell proliferation. Importantly, 
these results indicate that DMSO treatment itself does not influence cell proliferation 
following injury. In contrast, total population of Ki67+ cells decreased in lesioned 
hemisphere compared to corresponding contralateral control hemisphere in individual 
SuBr3 H-I animals except for A3* (Fig. 5).  
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Since the animals were stereotactically injected with either DMSO or SuBr3 prior 
to being subjected to H-I and the injection procedure itself can induce injury mediated cell 
proliferation, we next compared the total numbers of Ki67+ cells amongst all the control 
and experimental groups: True Controls (animals that did not undergo H-I or ICV 
injections; n=2), DMSO Control (animals that received DMSO ICV injections only; n=2), 
DMSO H-I (animals that received DMSO ICV injections and also underwent H-I; n=3), 
and SuBr3 Control (animal that received SuBr3 ICV injection only; n=2) and SuBr3 H-I 
(animals that received SuBr3 ICV injections and also underwent H-I; n=4) (Fig. 8). 
Compared to DMSO H-I group, total Ki67+ cell counts in the SuBr3 H-I group were 
significantly decreased (Fig. 8). Collectively, these results support that SuBr3 selectively 
blocks a cell proliferative response in the white matter lesions generated by H-I and this 
may be linked to HA breakdown.  
 
Does SuBr3 Influence OPC Proliferation Following H-I? 
H-I at P3 leads to reactive gliosis and OPC proliferation (Segovia et al., 2008) whereas 
SuBr3 treatment prior to H-I appears to attenuate total cell proliferation (Fig. 7); we next 
examined whether SuBr3 attenuated H-I induced OPC proliferation. To this end, the 
lesions from animals with confirmed WMI (Fig. 3 and Fig. 4) were double stained with 
Olig2 (labels the OL lineage cells) and Ki67 to determine proliferating OPCs.  
We compared the total number of Olig2+ and Olig2+-Ki67+-labeled cells in our 
control and experimental groups (Fig.8). Analyzing only Olig2+ cells, we determined that 
cell counts were significantly decreased in the SuBr3 H-I cell compared to the DMSO H-I 
group (Fig. 9A). This suggested that the SuBr3 influenced either the survival or 
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proliferation of OL lineage cells. We next examined the total numbers of proliferating 
OPCs by counting Olig2+-Ki67+ double labeled cells, but we were not able to detect any 
significant differences between the control and experimental groups (Fig. 9B). 
Collectively, these results suggest that attenuating HA breakdown following WMI by 
SuBr3 treatment may influence survival of OL lineage cells suggesting that under 
conditions of injury hyaluronidase activity may also play a protective role. It is not clear 
from our data regarding the identity of the glial or neuronal cell type whose proliferation 
is regulated by hyaluronidase activity as SuBr3 treatment attenuates the total pool of 
proliferating cells. Future studies, using a bigger cohort of animals and SuBr3 will examine 





















Figure 3.  Total GFAP-labeled cells in superior corpus callosum of four H-I 
injected SuBr3 animals. Total population of GFAP+-labeled astrocytes increased 
in lesioned areas compared to corresponding contralateral control region, 
however, treated animals displayed no significant difference in total cell counts 
between the lesion and corresponding contralateral control hemisphere (n=4). 
Confirmed injury through histology. 
 
 
























Figure 4.  Total GFAP-labeled cells in superior corpus callosum of H-I injected 
DMSO animals. Total population of GFAP+-labeled astrocytes increased in 











































Figure 5.  Total Ki-67 labeled cells in superior corpus callosum in same four H-I 
SuBr3 animals. Total population of Ki67+-labeled cells decreased in lesioned 
hemisphere compared to corresponding contralateral control hemisphere in H-I 
injected SuBr3 animals (n=4). 
 





































Figure 6.  Total Ki-67 labeled cells in superior corpus callosum in same H-I 
DMSO animals. Total population of Ki67+-labeled cells was similar between 
lesioned hemisphere and corresponding contralateral control hemisphere. DMSO 







































Figure 7.  Representative images of the corpus callosum (CC) from rats that sustained 
WMI. Brain tissues were fixed and stained with glial fibrillary acidic protein (GFAP; 
red; to label astrocytes), cell-cycle marker (Ki67; green; to label cell proliferation), 
and 4 ́, 6- diamidino-2-phenyl-inodole (DAPI; blue; to label nuclei). To block 
hyaluronidase activity, animals were treated with SuBr3 (2μM). A) There is an 
increased localization of Ki67+ cells but decreased GFAP+ astrocytes in Control 
hemisphere and B) a decreased localization of Ki67+ cells and increased GFAP+ 









































Figure 8.  Combined mean Ki-67+-labeled cells in lesion hemisphere of H-I 
SuBr3 animals compared to all other control groups: True Control (n=2 
animals), DMSO Control (n=2 animals), DMSO H-I (n=3 animals), and SuBr3 
Control (n=1 animals). Total cell counts in SuBr3 injected H-I lesion animals 




















Figure 9.  A) Pooled mean 
Olig2+-labeled counts in control 
groups: True Control (n=2 
animals), DMSO Control (n=1 
animals), DMSO H-I (n=3 
animals), and SuBr3 Control (n=1 
animals) compared to SuBr3 H-I 
animals (n=3 animals). SuBr3 H-I 
cell counts decreased significantly 
compared to DMSO H-I 
(*p=0.0123). B) Pooled Olig2+-
Ki67+-labeled cell counts were 
non-significant between the 






























Total Olig2+-Ki67+-labeled cells 
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Discussion 
Previous report from our lab has linked accumulation of HA and myelination failure 
that disrupts the maturation of the OL cell lineage in pre-term human neonates (Buser et 
al., 2012) (Fig. 1). WMI triggers neuronal and glial cell death, but the developing brain 
induces both migration and proliferation of OPCs into the white matter lesions resulting in 
expansion of the preOL pool. However, these newly formed preOLs then fail to mature 
into myelin producing OLs. Thus, myelination failure and breakdown of the ECM 
contributes to abnormal brain repair after WMI (Back and Rosenberg, 2014). By 
employing a new selective hyaluronidase inhibitor, SuBr3, we investigated the potential 
outcomes of attenuating ECM breakdown following WMI in vivo. Our present study 
suggests that HMW-HA breakdown in vivo regulates cell proliferation in the white matter 
lesions.  
Although ECM breakdown is one of the main events that coordinates the events 
leading to myelination failure following WMI, the molecular mechanisms remain poorly 
defined (Lau et al., 2013). HMW-HA in its intact form negatively regulates cell 
proliferation by its breakdown either via hyaluronidase activity or oxidative stress 
promotes cell proliferation (Morrison et al., 2001; Preston and Sherman, 2013; Su et al., 
2016). A previous study utilizing an adult rodent model of WMI implicated PH20 
hyaluronidase in preventing the differentiation of preOLs to mature OLs (Preston et. al, 
2013).  That study relied on a general hyaluronidase inhibitor, which could potentially have 
off target effects and it also did not address whether ECM modification plays a role in OPC 
proliferation following WMI. To investigate the molecular mechanisms influencing OPC 
proliferation following WMI we took advantage of our rodent pre-term equivalent model 
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and tested a more selective hyaluronidase inhibitor, SuBr3. This inhibitor (SuBr3) is 
derived from apigenin (compounds with well-known anti-hyaluronidase activity) and has 
a flavonoid modification for increased solubility and efficacy (Srinavasa et al., 2014). We 
observed reduced number of proliferating cells in response to SuBr3 treatment in vivo. 
Specifically, the SuBr3 treated animals displayed a decrease in Ki67+ proliferating cells in 
lesioned hemispheres compared to corresponding contralateral control hemispheres (Fig. 
5). Furthermore, combined mean cell counts for Ki67+ cells in SuBr3 H-I lesion 
hemispheres decreased significantly compared to all other control groups (Fig. 8). 
Collectively, these results support that SuBr3 selectively blocks a cell proliferative 
response in the white matter lesions generated by H-I. Hence, these results suggest a 
mechanistic link between HMW-HA breakdown and OPC proliferation in vivo. 
 Since WMI drives cell proliferation of OPCs in vivo (Segovia et al., 2008), we 
determined whether SuBr3 treatment could influence this event. We determined the total 
numbers of proliferating OPCs by counting Olig2+-Ki67+ double labeled cells, but were 
not able to detect any significant differences between the control and experimental groups 
(Fig. 9B). Surprisingly, we observed a significant decrease in the Olig2+-labeled cell 
population in SuBr3 treated animals compared to DMSO treated animals (Fig. 9A). 
Although the cohort of animals utilized for this preliminary study is small, nevertheless, 
these observations suggest that HMW-HA breakdown following WMI apart from 
regulating cell proliferation could also either influence the survival or migration of OL 
lineage cells in the WM lesions.  
Overall our findings indicate that the PH20 inhibitor, SuBr3, can be utilized to 
provide new insights into mechanisms that block normal myelination, and, thereby could 
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be helpful in developing new therapies to reverse arrested white matter maturation in 
survivors of premature birth. Since remyelination requires repair of the ECM and the 
sequential maturation of OL lineage in the WM lesions, it is critical to investigate the 
mechanisms following WMI by employing in vivo approaches. Since Olig2 labels all the 
cells of the OL lineage irrespective of their developmental stage, future experiments will 
analyze SuBr3 treatment utilizing a larger cohort of animals and OL cell stage specific 
markers in H-I lesions. Potential roles for hyaluronidase activity either in OL cell survival 
or migration will also be explored by using selective markers for cell death and migration. 
Additionally, future studies will attempt to define a time point in which analysis of both 
proliferating and arrested preOLs can be performed when the drug is administered. These 
efforts will provide further insights into strategies to promote preOL maturation that 
ultimately improve the neurological outcome for children with neurodevelopmental 
disabilities related to preterm birth. 
 











Back, S. A., Luo, N. L., Borenstein, N. S., Levine, J. M., Volpe, J. J., & Kinney, H. C. 
(2001). Late oligodendrocyte progenitors coincide with the developmental 
window of vulnerability for human perinatal white matter injury. J Neurosci. 
21(4), 1302–1312. 
Back, S. A., Han, B. H., Luo, N. L., Chricton, C. A., Xanthoudakis, S., Tam, J., Arvin, K. 
L., & Holtzman, D. M. (2002). Selective vulnerability of late oligodendrocyte 
progenitors to hypoxia–ischemia. J Neurosci, 22(2), 455-463. 
Back, S. A., Tuohy, T. M., Chen, H., Wallingford, N., Craig, A., Struve, J., … Sherman, 
L. S. (2005). Hyaluronan accumulates in demyelinated lesions and inhibits 
oligodendrocyte progenitor maturation. Nature Medicine, 11(9), 966 – 972. 
Back, S. A. & Miller, S. P. (2014). Brain injury in premature neonates: A primary 
cerebral dysmaturation disorder? Annals of Neurology, 75(4), 469–486. 
Back, S. A. & Rosenberg, P.A. (2014). Pathophysiology of glia in perinatal white matter 
injury. Glia; 62(11), 1790-1815. 
Blencowe, H., Cousens, S., Chou, D., Oestergaard, M., Say, L., Moller, A.-B., … Lawn, 
J. (2013). Born Too Soon: The global epidemiology of 15 million preterm 
births. Reproductive Health, 10(Suppl 1), S2.  
Buser, J. R., Maire, J., Riddle, A., Gong, X., Nguyen, T., Nelson, K., …Stephen, S. A. 
(2012). Arrested preoligodendrocyte maturation contributes to myelination failure 
in premature infants. Ann Neurol, 71(2), 93–109. 
 
 31 
Centers for Disease Control and Prevention. (2010).  Preterm birth. Retrieved from 
http://www.cdc.gov/reproductivehealth/maternalinfanthealth/pretermbirth.htm 
Chau, V., Synnes, A., Grunau, R. E., Poskitt, K. J., Brant, R., & Miller, S. P. (2013). 
Abnormal brain maturation in preterm neonates associated with adverse 
developmental outcomes. Neurology, 81(24), 2082–2089.  
Craig, A., Luo, N. L., Beardsley, D. J., Wingate-Pearse, N., Walker, D. W., Hohimer, A. 
R., & Back, S. A. (2003). Quantitative analysis of perinatal rodent 
oligodendrocyte lineage progression and its correlation with human. Exp. Neurol, 
181(2), 231–240. 
Dean, J. M., Riddle, A., Maire, J., Hansen, K. D., Preston, M., Barnes, A. P., … Back, S. 
A. (2011). An organotypic slice culture model of chronic white matter injury with 
maturation arrest of oligodendrocyte progenitors. Molecular 
Neurodegeneration, 6(1), [46].  
Khwaja, O., & Volpe, J. J. (2008). Pathogenesis of cerebral white matter injury of 
prematurity. Archives of Disease in Childhood. Fetal and Neonatal Edition, 93(2), 
F153–F161.  
Lau, L. W., Cua, R., Keough, M. B., Haylock-Jacobs, S., & Yong, V. W. (2013). 
Pathophysiology of the brain extracellular matrix: a new target for remyelination. 
Nature Reviews Neuroscience, 14(10), 722–729. 
Lyck, L., Dalmau, I., Chemnitz, J., Finsen, B., & Schrøder, H. D. (2008). 
Immunohistochemical markers for quantitative studies of neurons and glia in 
human neocortex. J Histo Cytochem, 56(3), 201–221.  
 32 
Morrison, H., Sherman, L.S., Legg, J., Banine, F., Isacke, C., Haipek, C.A.,…Herrlich, P. 
(2001). The NF2 tumor suppressor gene product, merlin, mediates contact 
inhibition of growth through interactions with CD44. Genes Dev, 15(8), 968–980. 
Preston, M., Gong, X., Su, W., Matsumoto, S. G., Banine, F., Winkler, C., … Sherman, 
L. S. (2013). Digestion products of the ph20 hyaluronidase inhibit 
remyelination. Annals of Neurology, 73(2), 266–280. 
Rauch, U. (2004). Extracellular matrix components associated with remodeling processes 
in brain. Cellular and Molecular Life Sciences, 61(16), 2031–2045. 
Scholzen, T. & Gerdes, J. (2000). The Ki-67 protein: from the known and the unknown. 
J Cell Physiol, 182(3), 311–322. 
Segovia, K. N., McClure, M., Moravec, M., Luo, N. L., Wan, Y., Gong, X., … Back, S. 
A. (2008). Arrested oligodendrocyte lineage maturation in chronic perinatal white 
matter injury. Annals of Neurology, 63(4), 520–530.  
Shechter, R., Miller, O., Yovel, G., Rosenzweig, N., London, A., Ruckh, J., … Schwartz, 
M. (2013). Recruitment of beneficial M2 macrophages to injured spinal cord is 
orchestrated by remote brain choroid plexus. Immunity, 38(3), 555–569.  
Sherman, L. S., and Back, S.A. (2008). A ’GAG’ reflex prevents repair of the damaged 
CNS. Trends Neurosci. 31(1), 44–52. 
Sherman, L., Matsumoto, S., Su, W., Srivastava, T., & Back, S. A. (2015). Hyaluronan 
synthesis, catabolism, and signaling in neurodegenerative diseases. International 
Journal of Cell Biology, vol. 2015, Article ID 368584, 1-10. 
 33 
Srinivasa, V., Sundaram, M. S., Anusha, S., Hemshekhar, M., Chandra Nayaka, S., 
Kemparaju, K.,…Rangappa, K. S. (2014). Novel Apigenin Based Small Molecule 
that Targets Snake Venom Metalloproteases. PLoS ONE 9(9): e106364.  
Su, W., Foster, S., Xing, R., Feistel, K., Olsen, R., Acevedo, S., … Sherman, L. (2017). 
CD44 transmembrane receptor and hyaluronan regulate adult hippocampal neural 
stem cell quiescence and differentiation. J Biol Chem, 292(11), 4434-4445. 
Vannucci, R. C., Connor, J. R., Mauger, D. T., Palmer, C., Smith, M. B., Towfighi, J., & 
Vannucci, S. J. (1999). Rat model of perinatal hypoxic-ischemic brain damage. J 
Neurosci Res, 55(2), 158 –163. 
Volpe, J. J. (2001). Neurobiology of periventricular leukomalacia in the premature infant. 
Pediatr Res, 50, 553–56. 
Volpe, J. J. (2009). Brain injury in premature infants: a complex amalgam of destructive 
and developmental disturbances. Lancet Neurol, 8, 110–124.  
 
